|
Volumn 148, Issue 5, 2008, Pages 370-378
|
Current pharmacologic treatment of dementia: A clinical practice guideline from the American college of physicians and the American academy of family physicians
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
GALANTAMINE;
IDEBENONE;
MEMANTINE;
RIVASTIGMINE;
TACRINE;
AMINO ACID RECEPTOR BLOCKING AGENT;
CARBAMIC ACID DERIVATIVE;
INDAN DERIVATIVE;
PIPERIDINE DERIVATIVE;
ABNORMAL DREAMING;
AGITATION;
ALZHEIMER DISEASE;
ANOREXIA;
BEHAVIOR;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COGNITION;
COGNITIVE DEFECT;
DAILY LIFE ACTIVITY;
DEMENTIA;
DIARRHEA;
DIZZINESS;
DRUG COST;
DRUG TOLERABILITY;
EATING DISORDER;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
INSOMNIA;
LEG CRAMP;
LIVER INJURY;
MOOD;
MULTIINFARCT DEMENTIA;
MUSCLE CRAMP;
NAUSEA;
NAUSEA AND VOMITING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
SIDE EFFECT;
WEIGHT REDUCTION;
AFFECT;
ARTICLE;
PSYCHOLOGICAL ASPECT;
ACTIVITIES OF DAILY LIVING;
AFFECT;
CHOLINESTERASE INHIBITORS;
COGNITION;
DEMENTIA;
EXCITATORY AMINO ACID ANTAGONISTS;
GALANTAMINE;
HUMANS;
INDANS;
MEMANTINE;
PHENYLCARBAMATES;
PIPERIDINES;
QUALITY OF LIFE;
TACRINE;
|
EID: 41049104686
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-5-200803040-00008 Document Type: Review |
Times cited : (322)
|
References (63)
|